Physician

Adam C Smithee, MD

According to 2025 Medicare claims, Adam Smithee, MD (NPI: 1144757592) practices dermatology in the Austin-Round Rock-San Marcos, TX market, with the plurality of this provider's patient population coming from Travis, TX. This provider's primary affiliated billing organization is WESTLAKE DERMATOLOGY PA (NPI: 1518939347; TIN: 820540404) and primary practice location at 78746-4721.

Smithee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 389 traditional Medicare patients, billed 2,347 HCPCS/CPT codes, and received $78,117 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 310 prescription claims across 169 beneficiaries totaling $84,299 in drug costs, led by Triamcinolone Acetonide (Triamcinolone Acetonide). Open Payments data shows 73 records totaling $1,509. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have fallen sharply in recent years, from $1,341 to $84,299. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$39K$78K2021 Medicare payment: $10,521 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $46,766 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $69,594 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $78,117 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202172175$10,521
20223021,110$46,766
20233621,892$69,594
20243892,347$78,117

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$196K$391K2017 Drug cost: $1,341 (USD; Tot_Drug_Cst)2018 Drug cost: $92,287 (USD; Tot_Drug_Cst)2019 Drug cost: $252,090 (USD; Tot_Drug_Cst)2020 Drug cost: $391,399 (USD; Tot_Drug_Cst)2021 Drug cost: $156,031 (USD; Tot_Drug_Cst)2022 Drug cost: $16,501 (USD; Tot_Drug_Cst)2023 Drug cost: $25,443 (USD; Tot_Drug_Cst)2024 Drug cost: $84,299 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R17$1,341
201878187$92,287
2019104386$252,090
2020113538$391,399
202179237$156,031
2022121224$16,501
2023141226$25,443
2024169310$84,299

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths98114$77
11102Biopsy of related skin growth, first growth113124$65
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more235307$60
17000Destruction of precancer skin growth, 1 growth158200$39
17003Destruction of precancer skin growth, 2-14 growths113481$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Triamcinolone AcetonideTriamcinolone Acetonide752,382$845
FluocinonideFluocinonide14450$527
KetoconazoleKetoconazole401,060$506
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc19554$162
MupirocinMupirocin19339$113

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.73$1,509ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam C. Smithee, MD?

Tedicare shows public-source Medicare data for Adam C. Smithee, MD (NPI 1144757592), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam C. Smithee, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam C. Smithee, MD?

Adam C. Smithee, MD is linked to WESTLAKE DERMATOLOGY PA (billing NPI 1518939347) in the available physician profile data.

Does Adam C. Smithee, MD have Open Payments data?

Adam C. Smithee, MD has 73 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.